Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,177
archived clinical trials in
Orthopedic

A Study of SI-6603 in Patients With Lumbar Disc Herniation
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Newnan, GA
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Newnan, GA
Click here to add this to my saved trials
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Bloomington, IL
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Bloomington, IL
Click here to add this to my saved trials
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Carmel, IN
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Carmel, IN
Click here to add this to my saved trials
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Shreveport, LA
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Shreveport, LA
Click here to add this to my saved trials
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Hartsdale, NY
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Hartsdale, NY
Click here to add this to my saved trials
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Eugene, OR
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Eugene, OR
Click here to add this to my saved trials
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
State College, PA
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
State College, PA
Click here to add this to my saved trials
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Charleston, SC
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Sandy, UT
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Sandy, UT
Click here to add this to my saved trials
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Edmonds, WA
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Edmonds, WA
Click here to add this to my saved trials
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Murrieta, CA
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Murrieta, CA
Click here to add this to my saved trials
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Riverside, CA
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Riverside, CA
Click here to add this to my saved trials
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Denver, CO
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Merritt Island, FL
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Merritt Island, FL
Click here to add this to my saved trials
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Naples, FL
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Naples, FL
Click here to add this to my saved trials
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
North Miami Beach, FL
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
North Miami Beach, FL
Click here to add this to my saved trials
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Dallas, TX
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Gold River, CA
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Gold River, CA
Click here to add this to my saved trials
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Saint Petersburg, FL
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Saint Peters, MO
A Study of SI-6603 in Patients With Lumbar Disc Herniation
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Saint Peters, MO
Click here to add this to my saved trials
Evaluation of Budesonide and How It Interacts With Antifungal Drugs in People With Gastrointestinal Graft-Versus-Host Disease
Evaluation of Serum Concentrations of Budesonide in Patients Treated for Gastrointestinal Graft-Versus-Host Disease and the Potential Interaction With Fluconazole or Voriconazole
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Evaluation of Budesonide and How It Interacts With Antifungal Drugs in People With Gastrointestinal Graft-Versus-Host Disease
Evaluation of Serum Concentrations of Budesonide in Patients Treated for Gastrointestinal Graft-Versus-Host Disease and the Potential Interaction With Fluconazole or Voriconazole
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Comparison of Two Thoracic Manipulation Techniques to Improve Neck Pain in Dentistry Students
A Comparison of Two Thoracic Manipulation Techniques to Improve Neck Pain in Dentistry Students: a Randomized Controlled Trial.
Status: Enrolling
Updated:  12/31/1969
A. T. Still University
mi
from
Mesa, AZ
Comparison of Two Thoracic Manipulation Techniques to Improve Neck Pain in Dentistry Students
A Comparison of Two Thoracic Manipulation Techniques to Improve Neck Pain in Dentistry Students: a Randomized Controlled Trial.
Status: Enrolling
Updated: 12/31/1969
A. T. Still University
mi
from
Mesa, AZ
Click here to add this to my saved trials
A Study of Novel Immune Modulating Biomarkers in Patients With Spondyloarthritis With Axial Involvement
A Study of Novel Immune Modulating Biomarkers in Patients With Spondyloarthritis With Axial Involvement
Status: Enrolling
Updated:  12/31/1969
Hospital for Special Surgery
mi
from
New York, NY
A Study of Novel Immune Modulating Biomarkers in Patients With Spondyloarthritis With Axial Involvement
A Study of Novel Immune Modulating Biomarkers in Patients With Spondyloarthritis With Axial Involvement
Status: Enrolling
Updated: 12/31/1969
Hospital for Special Surgery
mi
from
New York, NY
Click here to add this to my saved trials
Decadron as Adjuvant in Femoral Nerve Blocks in Knee Arthroscopy
Dexamethasone as an Adjuvant to Ropivacaine for Femoral Nerve Blocks in Children Undergoing Knee Arthroscopy
Status: Enrolling
Updated:  12/31/1969
Nationwide Children's Hospital
mi
from
Columbus, OH
Decadron as Adjuvant in Femoral Nerve Blocks in Knee Arthroscopy
Dexamethasone as an Adjuvant to Ropivacaine for Femoral Nerve Blocks in Children Undergoing Knee Arthroscopy
Status: Enrolling
Updated: 12/31/1969
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
A Study to Evaluate Safety and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation
Open-Label, Non-controlled, Single Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Birmingham, AL
A Study to Evaluate Safety and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation
Open-Label, Non-controlled, Single Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study to Evaluate Safety and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation
Open-Label, Non-controlled, Single Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Phoenix, AZ
A Study to Evaluate Safety and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation
Open-Label, Non-controlled, Single Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study to Evaluate Safety and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation
Open-Label, Non-controlled, Single Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Encinitas, CA
A Study to Evaluate Safety and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation
Open-Label, Non-controlled, Single Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Encinitas, CA
Click here to add this to my saved trials
A Study to Evaluate Safety and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation
Open-Label, Non-controlled, Single Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
San Francisco, CA
A Study to Evaluate Safety and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation
Open-Label, Non-controlled, Single Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Study to Evaluate Safety and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation
Open-Label, Non-controlled, Single Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Orlando, FL
A Study to Evaluate Safety and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation
Open-Label, Non-controlled, Single Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study to Evaluate Safety and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation
Open-Label, Non-controlled, Single Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Atlanta, GA
A Study to Evaluate Safety and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation
Open-Label, Non-controlled, Single Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study to Evaluate Safety and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation
Open-Label, Non-controlled, Single Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Chicago, IL
A Study to Evaluate Safety and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation
Open-Label, Non-controlled, Single Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study to Evaluate Safety and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation
Open-Label, Non-controlled, Single Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Lexington, KY
A Study to Evaluate Safety and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation
Open-Label, Non-controlled, Single Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Lexington, KY
Click here to add this to my saved trials
A Study to Evaluate Safety and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation
Open-Label, Non-controlled, Single Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Royal Oak, MI
A Study to Evaluate Safety and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation
Open-Label, Non-controlled, Single Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Royal Oak, MI
Click here to add this to my saved trials
A Study of Muscle Strength Maintenance in Older Adults
A Study of Muscle Strength Maintenance in Older Adults
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Bayview Clinical Research Unit
mi
from
Baltimore, MD
A Study of Muscle Strength Maintenance in Older Adults
A Study of Muscle Strength Maintenance in Older Adults
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Bayview Clinical Research Unit
mi
from
Baltimore, MD
Click here to add this to my saved trials
Abatacept as GVHD Prophylaxis Phase 2
Abatacept Combined With a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease Prophylaxis: A Randomized Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Children's Hospital Colorado
mi
from
Aurora, CO
Abatacept as GVHD Prophylaxis Phase 2
Abatacept Combined With a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease Prophylaxis: A Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Abatacept as GVHD Prophylaxis Phase 2
Abatacept Combined With a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease Prophylaxis: A Randomized Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Childrens National Medical Center
mi
from
Washington,
Abatacept as GVHD Prophylaxis Phase 2
Abatacept Combined With a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease Prophylaxis: A Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Childrens National Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Abatacept as GVHD Prophylaxis Phase 2
Abatacept Combined With a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease Prophylaxis: A Randomized Controlled Trial
Status: Enrolling
Updated:  12/31/1969
University of Florida
mi
from
Gainesville, FL
Abatacept as GVHD Prophylaxis Phase 2
Abatacept Combined With a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease Prophylaxis: A Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Abatacept as GVHD Prophylaxis Phase 2
Abatacept Combined With a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease Prophylaxis: A Randomized Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Children's Healthcare of Atlanta - Egleston
mi
from
Atlanta, GA
Abatacept as GVHD Prophylaxis Phase 2
Abatacept Combined With a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease Prophylaxis: A Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Children's Healthcare of Atlanta - Egleston
mi
from
Atlanta, GA
Click here to add this to my saved trials
Abatacept as GVHD Prophylaxis Phase 2
Abatacept Combined With a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease Prophylaxis: A Randomized Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Emory University Winship Cancer Center
mi
from
Atlanta, GA
Abatacept as GVHD Prophylaxis Phase 2
Abatacept Combined With a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease Prophylaxis: A Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Emory University Winship Cancer Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
Abatacept as GVHD Prophylaxis Phase 2
Abatacept Combined With a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease Prophylaxis: A Randomized Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Abatacept as GVHD Prophylaxis Phase 2
Abatacept Combined With a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease Prophylaxis: A Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Abatacept as GVHD Prophylaxis Phase 2
Abatacept Combined With a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease Prophylaxis: A Randomized Controlled Trial
Status: Enrolling
Updated:  12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Abatacept as GVHD Prophylaxis Phase 2
Abatacept Combined With a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease Prophylaxis: A Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Abatacept as GVHD Prophylaxis Phase 2
Abatacept Combined With a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease Prophylaxis: A Randomized Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Michael Grimley
mi
from
Cincinnati, OH
Abatacept as GVHD Prophylaxis Phase 2
Abatacept Combined With a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease Prophylaxis: A Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Michael Grimley
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Abatacept as GVHD Prophylaxis Phase 2
Abatacept Combined With a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease Prophylaxis: A Randomized Controlled Trial
Status: Enrolling
Updated:  12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Abatacept as GVHD Prophylaxis Phase 2
Abatacept Combined With a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease Prophylaxis: A Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Abatacept as GVHD Prophylaxis Phase 2
Abatacept Combined With a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease Prophylaxis: A Randomized Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Seattle Cancer Care Alliance
mi
from
Seattle, WA
Abatacept as GVHD Prophylaxis Phase 2
Abatacept Combined With a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease Prophylaxis: A Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Seattle Cancer Care Alliance
mi
from
Seattle, WA
Click here to add this to my saved trials
Abatacept as GVHD Prophylaxis Phase 2
Abatacept Combined With a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease Prophylaxis: A Randomized Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Children's and Women's Health Center of BC
mi
from
Vancouver,
Abatacept as GVHD Prophylaxis Phase 2
Abatacept Combined With a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease Prophylaxis: A Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Children's and Women's Health Center of BC
mi
from
Vancouver,
Click here to add this to my saved trials
Abatacept as GVHD Prophylaxis Phase 2
Abatacept Combined With a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease Prophylaxis: A Randomized Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Abatacept as GVHD Prophylaxis Phase 2
Abatacept Combined With a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease Prophylaxis: A Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Abatacept as GVHD Prophylaxis Phase 2
Abatacept Combined With a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease Prophylaxis: A Randomized Controlled Trial
Status: Enrolling
Updated:  12/31/1969
UCSF Benioff Children's Hospital Oakland
mi
from
Oakland, CA
Abatacept as GVHD Prophylaxis Phase 2
Abatacept Combined With a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease Prophylaxis: A Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
UCSF Benioff Children's Hospital Oakland
mi
from
Oakland, CA
Click here to add this to my saved trials
Abatacept as GVHD Prophylaxis Phase 2
Abatacept Combined With a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease Prophylaxis: A Randomized Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Kapiolani Medical Center for Women and Children
mi
from
Honolulu, HI
Abatacept as GVHD Prophylaxis Phase 2
Abatacept Combined With a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease Prophylaxis: A Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Kapiolani Medical Center for Women and Children
mi
from
Honolulu, HI
Click here to add this to my saved trials
Abatacept as GVHD Prophylaxis Phase 2
Abatacept Combined With a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease Prophylaxis: A Randomized Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Lurie Children's Hospital
mi
from
Chicago, IL
Abatacept as GVHD Prophylaxis Phase 2
Abatacept Combined With a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease Prophylaxis: A Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Lurie Children's Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Abatacept as GVHD Prophylaxis Phase 2
Abatacept Combined With a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease Prophylaxis: A Randomized Controlled Trial
Status: Enrolling
Updated:  12/31/1969
University of Chicago
mi
from
Chicago, IL
Abatacept as GVHD Prophylaxis Phase 2
Abatacept Combined With a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease Prophylaxis: A Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials